MK-801 does not prevent acute stimulatory effects of amphetamine or cocaine on locomotor activity or extracellular dopamine levels in rat nucleus accumbens

Marina Wolf, Chang Jiang Xue, Francis J. White, Susan L. Dahlin

Research output: Contribution to journalArticle

52 Citations (Scopus)

Abstract

Recent work has shown that the development of behavioral sensitization to cocaine, amphetamine, and morphine is prevented by coadministration of N-methyl-d-aspartate (NMDA) antagonists such as MK-801. This suggests that NMDA receptors mediate long-term changes in neuronal responsiveness essential for the development of behavioral sensitization, similar to their role in other forms of neuronal plasticity. However, other studies, suggesting that NMDA receptor antagonists interfere with acute behavioral effects of psychomotor stimulants, call this interpretation into question and suggest that the ability of NMDA antagonists to prevent sentization may reflect blockade of the acute effects of psychomotor stimulants. To examine this issue, behavioral and microdialysis studies assessed the effect of pretreatment with 0.1 mg/kg MK-801 on the ability of amphetamine and cocaine to stimulate locomotor activity and elevate dopamine (DA) levels in nucleus accumbens; this dose of MK-801 prevents sensitization when coadministered repeatedly with these stimulants. MK-801 pretreatment enhanced amphetamine-stimulated horizontal locomotion and stereotyped behavior. MK-801 pretreatment produced a modest attenuation of cocaine-stimulated horizontal locomotion, which may have reflected enhancement by MK-801 of certain components of cocaine-stimulated stereotyped. There was no effect of MK-801 pretreatment on the ability to amphetamine or cocaine to elevate extracellular DA levels in nucleus accumbens. These results suggest that the acute effects of cacaine and amphetamine on locomotor activity and extracellular DA levels are not prevented by MK-801 through other mechanisms to prevent the development of behavioral sensitization.

Original languageEnglish (US)
Pages (from-to)223-231
Number of pages9
JournalBrain research
Volume666
Issue number2
DOIs
StatePublished - Dec 15 1994
Externally publishedYes

Fingerprint

Dizocilpine Maleate
Nucleus Accumbens
Amphetamine
Locomotion
Cocaine
Dopamine
Aptitude
Aspartic Acid
Stereotyped Behavior
Neuronal Plasticity
Microdialysis
Morphine

Keywords

  • Amphetamine
  • Cocaine
  • Dopamine
  • Microdialysis
  • MK-801
  • Nucleus accumbens
  • Sensitization

ASJC Scopus subject areas

  • Neuroscience(all)
  • Molecular Biology
  • Developmental Biology
  • Clinical Neurology

Cite this

MK-801 does not prevent acute stimulatory effects of amphetamine or cocaine on locomotor activity or extracellular dopamine levels in rat nucleus accumbens. / Wolf, Marina; Xue, Chang Jiang; White, Francis J.; Dahlin, Susan L.

In: Brain research, Vol. 666, No. 2, 15.12.1994, p. 223-231.

Research output: Contribution to journalArticle

@article{f4566723eed345e5b9224124ac606013,
title = "MK-801 does not prevent acute stimulatory effects of amphetamine or cocaine on locomotor activity or extracellular dopamine levels in rat nucleus accumbens",
abstract = "Recent work has shown that the development of behavioral sensitization to cocaine, amphetamine, and morphine is prevented by coadministration of N-methyl-d-aspartate (NMDA) antagonists such as MK-801. This suggests that NMDA receptors mediate long-term changes in neuronal responsiveness essential for the development of behavioral sensitization, similar to their role in other forms of neuronal plasticity. However, other studies, suggesting that NMDA receptor antagonists interfere with acute behavioral effects of psychomotor stimulants, call this interpretation into question and suggest that the ability of NMDA antagonists to prevent sentization may reflect blockade of the acute effects of psychomotor stimulants. To examine this issue, behavioral and microdialysis studies assessed the effect of pretreatment with 0.1 mg/kg MK-801 on the ability of amphetamine and cocaine to stimulate locomotor activity and elevate dopamine (DA) levels in nucleus accumbens; this dose of MK-801 prevents sensitization when coadministered repeatedly with these stimulants. MK-801 pretreatment enhanced amphetamine-stimulated horizontal locomotion and stereotyped behavior. MK-801 pretreatment produced a modest attenuation of cocaine-stimulated horizontal locomotion, which may have reflected enhancement by MK-801 of certain components of cocaine-stimulated stereotyped. There was no effect of MK-801 pretreatment on the ability to amphetamine or cocaine to elevate extracellular DA levels in nucleus accumbens. These results suggest that the acute effects of cacaine and amphetamine on locomotor activity and extracellular DA levels are not prevented by MK-801 through other mechanisms to prevent the development of behavioral sensitization.",
keywords = "Amphetamine, Cocaine, Dopamine, Microdialysis, MK-801, Nucleus accumbens, Sensitization",
author = "Marina Wolf and Xue, {Chang Jiang} and White, {Francis J.} and Dahlin, {Susan L.}",
year = "1994",
month = "12",
day = "15",
doi = "10.1016/0006-8993(94)90776-5",
language = "English (US)",
volume = "666",
pages = "223--231",
journal = "Brain Research",
issn = "0006-8993",
publisher = "Elsevier",
number = "2",

}

TY - JOUR

T1 - MK-801 does not prevent acute stimulatory effects of amphetamine or cocaine on locomotor activity or extracellular dopamine levels in rat nucleus accumbens

AU - Wolf, Marina

AU - Xue, Chang Jiang

AU - White, Francis J.

AU - Dahlin, Susan L.

PY - 1994/12/15

Y1 - 1994/12/15

N2 - Recent work has shown that the development of behavioral sensitization to cocaine, amphetamine, and morphine is prevented by coadministration of N-methyl-d-aspartate (NMDA) antagonists such as MK-801. This suggests that NMDA receptors mediate long-term changes in neuronal responsiveness essential for the development of behavioral sensitization, similar to their role in other forms of neuronal plasticity. However, other studies, suggesting that NMDA receptor antagonists interfere with acute behavioral effects of psychomotor stimulants, call this interpretation into question and suggest that the ability of NMDA antagonists to prevent sentization may reflect blockade of the acute effects of psychomotor stimulants. To examine this issue, behavioral and microdialysis studies assessed the effect of pretreatment with 0.1 mg/kg MK-801 on the ability of amphetamine and cocaine to stimulate locomotor activity and elevate dopamine (DA) levels in nucleus accumbens; this dose of MK-801 prevents sensitization when coadministered repeatedly with these stimulants. MK-801 pretreatment enhanced amphetamine-stimulated horizontal locomotion and stereotyped behavior. MK-801 pretreatment produced a modest attenuation of cocaine-stimulated horizontal locomotion, which may have reflected enhancement by MK-801 of certain components of cocaine-stimulated stereotyped. There was no effect of MK-801 pretreatment on the ability to amphetamine or cocaine to elevate extracellular DA levels in nucleus accumbens. These results suggest that the acute effects of cacaine and amphetamine on locomotor activity and extracellular DA levels are not prevented by MK-801 through other mechanisms to prevent the development of behavioral sensitization.

AB - Recent work has shown that the development of behavioral sensitization to cocaine, amphetamine, and morphine is prevented by coadministration of N-methyl-d-aspartate (NMDA) antagonists such as MK-801. This suggests that NMDA receptors mediate long-term changes in neuronal responsiveness essential for the development of behavioral sensitization, similar to their role in other forms of neuronal plasticity. However, other studies, suggesting that NMDA receptor antagonists interfere with acute behavioral effects of psychomotor stimulants, call this interpretation into question and suggest that the ability of NMDA antagonists to prevent sentization may reflect blockade of the acute effects of psychomotor stimulants. To examine this issue, behavioral and microdialysis studies assessed the effect of pretreatment with 0.1 mg/kg MK-801 on the ability of amphetamine and cocaine to stimulate locomotor activity and elevate dopamine (DA) levels in nucleus accumbens; this dose of MK-801 prevents sensitization when coadministered repeatedly with these stimulants. MK-801 pretreatment enhanced amphetamine-stimulated horizontal locomotion and stereotyped behavior. MK-801 pretreatment produced a modest attenuation of cocaine-stimulated horizontal locomotion, which may have reflected enhancement by MK-801 of certain components of cocaine-stimulated stereotyped. There was no effect of MK-801 pretreatment on the ability to amphetamine or cocaine to elevate extracellular DA levels in nucleus accumbens. These results suggest that the acute effects of cacaine and amphetamine on locomotor activity and extracellular DA levels are not prevented by MK-801 through other mechanisms to prevent the development of behavioral sensitization.

KW - Amphetamine

KW - Cocaine

KW - Dopamine

KW - Microdialysis

KW - MK-801

KW - Nucleus accumbens

KW - Sensitization

UR - http://www.scopus.com/inward/record.url?scp=0028053834&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0028053834&partnerID=8YFLogxK

U2 - 10.1016/0006-8993(94)90776-5

DO - 10.1016/0006-8993(94)90776-5

M3 - Article

C2 - 7882032

AN - SCOPUS:0028053834

VL - 666

SP - 223

EP - 231

JO - Brain Research

JF - Brain Research

SN - 0006-8993

IS - 2

ER -